UN
UNFPA Partnership Catalyst

PMNCH in Plain Language: What It Is, How It Differs from UNFPA

UNFPA-O-05OrientationOrientationAudience: Both4,219 words

EXECUTIVE SUMMARY

The Partnership for Maternal, Newborn and Child Health (PMNCH) is one of the world's largest global health partnerships — a multi-stakeholder convening and accountability platform hosted by the World Health Organization (WHO) in Geneva. With over 1,000 member organisations spanning governments, civil society, academic institutions, health professional associations, donors, and the private sector, PMNCH occupies a distinct and important position in the global architecture for maternal, newborn, child, and adolescent health (MNCAH). What PMNCH is not, and what it is most commonly confused with, is an implementing agency: it does not run country programmes, employ field staff, procure supplies, or deliver services. Its power is convening, evidence synthesis, and accountability — the ability to bring the global community together, synthesise what the evidence says, and hold partners accountable for commitments they have made.

Understanding PMNCH requires holding the distinction between a convening platform and an implementing agency with some precision. PMNCH's roughly 35-person secretariat in Geneva manages a partnership of over 1,000 organisations across sectors and geographies. The secretariat's product is not programmes but rather the infrastructure of coordination: partner convening (the annual Partners' Forum, working groups, technical consultations), evidence synthesis (the flagship report What Works for Women and Children; the EWEC Progress Report), and accountability tracking (the Every Woman Every Child commitment database and reporting cycle). These outputs are valuable precisely because they aggregate across the entire global MNCAH community, not just one organisation's programme portfolio.

PMNCH's relationship with UNFPA is complementary rather than competitive, but the two organisations' mandates do overlap — particularly on maternal health, adolescent health, and SRHR — and the distinction between them needs to be understood clearly. UNFPA has a UN mandate, country presence, procurement capacity, and direct programme implementation. PMNCH has a multi-stakeholder platform including civil society and private sector voices in governance, an accountability function that tracks whether partners (including governments and donors) keep their commitments, and the credibility of WHO hosting for its normative outputs. Neither organisation can do what the other does, and both are needed in the global architecture.

PMNCH's current Strategic Plan runs from 2021 to 2025 and focuses on three strategic priorities: equity (ensuring the health agenda reaches the most marginalised), accountability (tracking and reporting on partner commitments more rigorously), and innovation (leveraging data, technology, and new partnerships). The plan positions PMNCH as a critical accountability infrastructure for the SDG 3 agenda and the EWEC movement in the final years before 2030.

KEY FACTS

BACKGROUND AND CONTEXT

Origins: The Fragmented Landscape That Spawned PMNCH

By the early 2000s, the global health field for maternal, newborn, and child health was characterised by a proliferation of partnerships, alliances, and initiatives — each focused on a segment of the problem, each with its own governance structure, each competing for donor funding and political attention. The maternal health community, the child survival community, and the newborn health community operated in largely separate institutional tracks, despite the obvious biological and programmatic links between them.

Several high-profile analyses — including the 2005 Lancet child survival series, the 2006 Lancet newborn survival series, and the 2006 Lancet maternal survival series — documented the fragmentation problem and made the case for integrated action. The creation of PMNCH in 2005 was a direct response: an attempt to create a single platform that could bridge the maternal, newborn, and child constituencies, bring together the diversity of actors working in this space, and speak with a single voice on the case for investment and accountability.

PMNCH was created through the merger of:

WHO was chosen as the hosting institution because of its technical authority in health standard-setting and its universal membership among governments — giving the new partnership both scientific credibility and political legitimacy.

The Every Woman Every Child Movement

PMNCH's most visible strategic partnership is with the Every Woman Every Child (EWEC) movement, launched by UN Secretary-General Ban Ki-moon in September 2010 at the UN General Assembly. EWEC was designed to mobilise political will and financial commitment for maternal, newborn, and child health during the final five years of the Millennium Development Goals period.

The original EWEC initiative (2010–2015) generated commitments of over USD 40 billion from governments, multilaterals, civil society, and the private sector. PMNCH was designated as the accountability platform — tracking whether those commitments were being delivered.

In 2015, the Global Strategy for Women's, Children's and Adolescents' Health (2016–2030) renewed and expanded the EWEC framework, extending it to the full SDG period and incorporating adolescent health explicitly. The strategy's three objectives — Survive, Thrive, Transform — provide the framing for PMNCH's current work.

PMNCH's A+++ accountability framework, developed to assess commitment quality, grades commitments on four criteria: ambitious (is the target meaningful?), aligned (does it address a documented need?), additional (is this genuinely new, not just relabelling existing activity?), and accountable (will the commitment be verifiably tracked?). This framework has been used to sharpen the accountability function, though critics note that self-reporting by partners on commitment delivery remains a limitation.

Adolescent Health: PMNCH's Expanded Mandate

PMNCH's 2021–2025 Strategic Plan reflects an explicit expansion of the partnership's focus to include adolescent health more prominently. This was driven by:

PMNCH established a formal Youth and Adolescent Network constituency in its governance structure — giving young people a formal role in the partnership's direction. This is a distinctive feature: few global health governance mechanisms include youth as formal constituency representatives rather than consultative stakeholders.

DETAIL

Core Functions: What PMNCH Actually Does

Advocacy PMNCH builds and communicates the case for investment in MNCAH and SRHR at global, regional, and national levels. This includes: producing and disseminating evidence synthesis; engaging in high-level political processes (UN General Assembly, G7/G8 health tracks, SDG review processes); organising or supporting advocacy campaigns; and mobilising its 1,000+ partner network for coordinated advocacy moments.

The advocacy function is most powerful when the entire partnership speaks with one voice. PMNCH's value proposition in advocacy is precisely its breadth — a statement signed by health professional organisations, civil society groups, research institutions, governments, donors, and the private sector simultaneously carries a weight that no single organisation's advocacy can match.

Accountability PMNCH tracks and publicly reports on the commitments made under the Every Woman Every Child framework and the Global Strategy. The EWEC commitment database contains thousands of commitments from hundreds of organisations; PMNCH's annual progress reporting assesses delivery against these commitments.

The accountability function creates reputational incentives: organisations that make public commitments and are then assessed on delivery face reputational costs if they underperform. This is "naming and (not quite) shaming" — PMNCH's reporting is factual and relatively diplomatic, but the public nature of the tracking means non-delivery has consequences.

Limitations of the accountability function: self-reporting remains the primary data source for commitment tracking; verification of reported delivery is limited; and the A+++ criteria are applied at commitment entry rather than continuously through the reporting cycle.

Knowledge Generation and Synthesis PMNCH's knowledge function produces evidence synthesis across the full MNCAH field — not primary research, but synthesis and translation of the research base into policy-relevant products.

Key knowledge products:

PMNCH's knowledge products benefit from the credibility of WHO hosting (access to WHO technical networks and data) and from the breadth of the partner network (inputs from academic institutions, NGOs, and health professionals across geographies).

Convening PMNCH convenes partners through: the biennial Partners' Forum (a major global health gathering); regional consultations; thematic working groups on specific issues (adolescent health, data and accountability, fragile and conflict-affected settings); and virtual coordination mechanisms.

The Partners' Forum typically attracts 1,000+ participants from across the nine constituencies and is one of the few global health gatherings where governments, civil society, health professionals, and the private sector are in the same room as peers rather than in the asymmetric relationships typical of donor-recipient or norm-setter/implementer dynamics.

Governance: The Multi-Stakeholder Board

PMNCH's governance is one of its most distinctive features. The Board includes elected representatives from all nine partner constituencies. This means:

This is structurally different from UNFPA's governance (an Executive Board of UN member states only) and from most UN bodies, where civil society and professional associations have observer status at best. PMNCH's multi-stakeholder governance gives it legitimacy across constituencies that UN-body governance cannot replicate.

The practical consequence: PMNCH can convene and speak for a broader constituency than any single UN agency. When PMNCH makes a statement on adolescent health policy, it speaks with the authority of health professional associations, academic researchers, civil society organisations, and youth networks — not just member states.

The limitation: a nine-constituency Board with diverse interests is inherently more difficult to align on specific positions than a government-led board. PMNCH's governance processes require significant consensus-building, which can slow decision-making and sometimes produces statements that are diplomatically broad rather than analytically sharp.

Health Professional Associations: A Distinctive Asset

One of PMNCH's most valuable partnership assets is its direct engagement with global health professional associations:

These organisations collectively represent clinical professionals in virtually every country. When PMNCH mobilises its health professional constituency, it is reaching the people who actually provide maternal, newborn, and child health services globally. This is a lever that UNFPA, operating primarily through government systems and development NGOs, does not have in the same way.

What PMNCH Does That UNFPA Does Not

Convenes the private sector as a governance constituent: PMNCH's multi-stakeholder model includes pharmaceutical companies, technology firms, and other private sector actors as formal governance partners with Board representation. UNFPA engages the private sector in specific programme areas (e.g., the Midwives for Change programme; digital health partnerships) but does not formally govern with private sector representation.

Tracks whether external actors keep their commitments: PMNCH's accountability function is specifically designed to track whether governments, donors, and partners outside PMNCH are delivering on public commitments. UNFPA reports on its own results; it does not track whether, for example, the UK government delivered on its Nairobi Summit pledge.

Cross-constituency knowledge brokering: PMNCH synthesises evidence and translates it for policy audiences across a wider range of sectors — government ministries, health professionals, civil society, private sector — than UNFPA typically serves with its knowledge products.

Youth governance: PMNCH's formal Youth and Adolescent Network constituency representation is a model that UNFPA does not replicate in its own governance.

What UNFPA Does That PMNCH Does Not

Country presence and programme implementation: UNFPA has 150+ country offices with programme portfolios ranging from family planning commodity procurement to humanitarian GBV coordination. PMNCH has a Geneva secretariat and no in-country operational presence.

Procurement: UNFPA is the world's largest multilateral contraceptive procurer. PMNCH has no procurement function.

Humanitarian operational role: UNFPA leads the GBV Area of Responsibility globally and is a critical operational actor in reproductive health emergencies. PMNCH has no humanitarian operational mandate.

UN mandate authority on SRHR: UNFPA is the designated UN lead for the ICPD Programme of Action — a formally intergovernmentally agreed mandate. PMNCH's authority derives from its broad coalition, not from an intergovernmental mandate in the same sense.

Normative guidance with UN authority: UNFPA produces technical guidance backed by its UN status and ICPD mandate. PMNCH produces evidence synthesis with the credibility of WHO hosting and broad partnership but without the same formal intergovernmental authority.

The Overlap Zone

Both PMNCH and UNFPA work on maternal health, both engage the SDG 3 accountability architecture, and both produce knowledge products on MNCAH and SRHR. The key differences even in this overlap:

Both organisations participated in the Nairobi Summit on ICPD+25 (2019) and use the three zeros (maternal deaths, unmet need, GBV) as a shared advocacy framework. This shared framing creates potential for confusion about respective contributions, but also creates a common agenda that enables coordination.

EVIDENCE BASE

Assessing PMNCH's impact is methodologically challenging for a convening platform — the causal chain from "PMNCH convened partners" to "health outcomes improved" is long, and attribution is very difficult. PMNCH's own accountability reporting and independent evaluations have grappled with this.

The most honest assessment of PMNCH's evidence base:

FUNDING AND RESOURCES

PMNCH's annual secretariat budget of approximately USD 10–20 million is funded through contributions from a relatively small number of large institutional donors. The Bill & Melinda Gates Foundation has historically been one of PMNCH's largest funders. Major government donors include Norway, the UK (FCDO), and the European Commission.

The secretariat budget does not capture the full value of PMNCH's activities — member organisations fund their own participation, which represents a much larger aggregate investment than the secretariat costs. However, the secretariat budget is the resource PMNCH controls, and its small size relative to UNFPA (approximately 1–2% of UNFPA's annual expenditure) reflects the fundamentally different business models of the two organisations.

PMNCH's funding is subject to donor priorities and is not as politically vulnerable as UNFPA's (because it is not targeted by the US political attacks that affect UNFPA's funding), but it is still dependent on a small number of large donors and is thus subject to concentration risk.

KEY DEBATES AND CONTESTED QUESTIONS

Is a 1,000-member partnership governable? The governance challenge of a partnership with over 1,000 organisations across nine constituencies is real. Maintaining a coherent strategic direction and a common voice while representing diverse interests is demanding. Critics of multi-stakeholder partnerships in global health (particularly in the tradition of Szlezák et al. 2010; Storeng and Béhague 2014) argue that they tend to produce lowest-common-denominator positions that avoid difficult trade-offs. PMNCH's defenders argue that the breadth of the coalition is precisely its value.

Does private sector inclusion in governance compromise advocacy independence? PMNCH's inclusion of pharmaceutical and technology companies as formal governance partners is valued by some as bringing innovation and resources; criticised by others as creating conflicts of interest that limit PMNCH's ability to take positions critical of private sector actors. This is a live debate in global health governance more broadly.

Is PMNCH's accountability function truly accountable? The most common critique: if commitment tracking relies on self-reporting by the organisations whose commitments are being tracked, the accountability function is compromised. PMNCH has strengthened its verification mechanisms over time, but the fundamental tension remains. Independent, third-party verification of commitment delivery would strengthen the function but is expensive and logistically challenging at the scale of the EWEC commitment database.

How does PMNCH add distinct value when WHO already convenes and sets standards? Since PMNCH is hosted by WHO and the WHO DG chairs the Board, some critics question whether PMNCH is genuinely distinct from WHO or whether it is an additional coordination layer that duplicates WHO's convening function. PMNCH's defenders argue that its multi-stakeholder governance model creates a genuinely different type of convening — one where civil society and health professionals are peers rather than observers — that WHO's member-state governance cannot replicate.

IMPLICATIONS BY AUDIENCE

For Frontline Staff

PMNCH is not the organisation to approach for operational support. If you need contraceptive commodities, programme funding, or humanitarian coordination, go to UNFPA (or other implementing agencies). PMNCH's value for frontline practitioners is primarily through its knowledge products — the evidence briefs and synthesis reports that translate the research base into programme-relevant guidance — and through the advocacy and accountability infrastructure that creates political space for the work.

Understanding PMNCH's accountability function is useful for national-level advocacy: if a government has made a commitment to EWEC (and most have), PMNCH's commitment database and reporting cycle are tools for civil society to hold that government accountable at the national level.

The PMNCH Partners' Forum, held biennially, is one of the most valuable global health convening events for practitioners who want to connect with the full range of actors in the MNCAH/SRHR space — not just implementers but researchers, donors, and advocates. It is worth attending when accessible.

For Decision-Makers and Funders

Funding PMNCH's secretariat is funding the convening and accountability infrastructure for the entire global MNCAH community. The cost-effectiveness argument is that a small secretariat investment maintains a platform that leverages a much larger aggregate investment by member organisations. This is a plausible argument for the convening and knowledge functions.

The accountability function has potential value for funders who want their own commitments tracked rigorously, but it is important to engage with the A+++ criteria before making commitments — commitments that are vague, non-additional, or untimed will not score well and will create accountability pressure.

PMNCH's governance model — with civil society, health professionals, and youth represented alongside governments and donors — creates a different type of accountability than UN governance structures. If you want to understand what health professionals and civil society in the MNCAH space actually think, PMNCH governance processes are one of the best intelligence sources available.

PMNCH and UNFPA serve different but complementary functions. A funder who only funds UNFPA is investing in implementation but not in the accountability and convening infrastructure. A funder who only funds PMNCH is investing in advocacy without operational delivery. The most coherent portfolio includes both.

For Researchers

PMNCH's governance model is an exemplar for research on multi-stakeholder partnerships in global health governance — a growing literature (Storeng and Béhague; Rushton and Williams; Sridhar and Tamashiro) that examines the implications of moving from state-centric to multi-stakeholder governance models for accountability, equity, and effectiveness.

The EWEC commitment database is a potentially rich research resource: it contains thousands of commitments from hundreds of organisations, with varying quality of specificity and varying rates of self-reported delivery. Analysis of commitment quality (using the A+++ framework) and its relationship to delivery could test theories of accountability in global governance.

PMNCH's own independent evaluations are publicly available and provide transparent assessments of the partnership's performance against its strategic objectives. These are useful primary sources for governance research and for comparative analysis of international health partnerships.

The question of whether convening and knowledge platforms like PMNCH improve health outcomes — the distal attribution question — is genuinely open and represents a research gap. Approaches might include: synthetic control methods comparing countries with strong vs. weak PMNCH engagement; comparative case studies of commitment delivery; or analysis of PMNCH's influence on WHO normative processes.

CURRENT STATUS AND FUTURE DIRECTIONS

PMNCH is operating under its 2021–2025 Strategic Plan, with the next plan in development for the 2026–2030 period. The 2021–2025 plan's three priorities (equity, accountability, innovation) have guided the partnership's work through the latter SDG period.

Key current developments:

SOURCES

RELATED DOCUMENTS

Something wrong or missing?

Flag an error, suggest a correction, or add context.

Send Feedback
← Back to Knowledge Base